Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that it has selected ASC36 oral tablets, its first oral amylin receptor peptide agonist, for clinical development. Ascletis expects to submit an ...

Many drugs are poorly water-soluble and lipophilic (fat-loving), and both pose challenges to bioavailability. As you’re probably aware, the human body, including the GI tract, is mostly water, so if a ...

Meloxicam is well absorbed after oral administration, with an absolute bioavailability of 89% that is not markedly affected by concomitant intake of food. Meloxicam reaches maximum plasma ...